Skip to main content
Evidence Snapshot

KG-1

CHEMBL612264 CELL-LINE Homo sapiens
Source Header

ChEMBL 36 via Core Engine

Target Snapshot 2026-09-13T15:06:22Z
Source · ChEMBL 36 via Core Engine
ChEMBL ChEMBL 36 CHEMBL612264
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats KG-1 as ChEMBL target CHEMBL612264. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
KG-1
CELL-LINE · Homo sapiens
As of 2026-09-13
ChEMBL target ID
CHEMBL612264
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Review-ready Target Rationale

Why KG-1 matters

As of 2026-09-13

KG-1 is reviewed as KG-1; the current evidence base includes 38 approved drugs, 702 compounds, and 170 assays, with lead potency reaching pChEMBL 10.1.

Disease context
Disease signal

Disease relevance is not yet populated for this evidence card.

This disease block keeps the Open Targets-ready contract explicit while current evidence comes from ChEMBL mechanism and indication mappings.

ChEMBL target record
Activity base
Portfolio and assay base

ChEMBL currently tracks 38 approved drugs, 702 compounds, and 170 assays for this target. The dominant activity type is IC50. CHEMBL4790597 is the current potency anchor at pChEMBL 10.1.

Use CHEMBL4790597 as the tractability anchor when discussing potency (pChEMBL 10.1).

Activity source · ChEMBL 36 via Core Engine
38 approved pChEMBL 10.1
Source Guidance

Start with the right source

Pick the first block or linked source that matches the review question in front of you.

Need the shortest review narrative first?
Review-ready Target Rationale
One-page rationale with as-of-date and attribution

Start with the review rationale when you need to explain why KG-1 matters before drilling into raw source blocks.

Jump to Review Rationale
Need stable protein naming or accession mapping?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Go back to the target snapshot when you need the naming and mapping contract, not just the summarized rationale.

Open Protein Context
Need disease fit or evidence level for program framing?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use the target snapshot disease block when you need the disease program and supporting signals, not only the card summary.

Open Disease Context

Snapshot State

No project snapshot selected. Export uses the live evidence card state.

702
Total Compounds
170
Total Assays
38
Approved Drugs
IC50: 571.0, EC50: 49.0
Activity Types

pChEMBL Activity Distribution

Top 5 Inhibitors (by pChEMBL)

Structure Compound pChEMBL Type Phase
No preferred name
CHEMBL4790597
 10.1 IC50 —
No preferred name
CHEMBL576982
 9.8 IC50 Approved
No preferred name
CHEMBL4448252
 9.4 IC50 —
No preferred name
CHEMBL5633382
 9.3 IC50 —
No preferred name
CHEMBL4765060
 9.3 IC50 —

Approved Drugs

Structure Compound First Approval
QUIZARTINIB
CHEMBL576982
 2023
SELUMETINIB
CHEMBL1614701
 2020
ERDAFITINIB
CHEMBL3545376
 2019
MIDOSTAURIN
CHEMBL608533
 2017
VENETOCLAX
CHEMBL3137309
 2016
OSIMERTINIB
CHEMBL3353410
 2015
PONATINIB
CHEMBL1171837
 2012
AXITINIB
CHEMBL1289926
 2012
PAZOPANIB
CHEMBL477772
 2009
TEMSIROLIMUS
CHEMBL1201182
 2007
VORINOSTAT
CHEMBL98
 2006
GEFITINIB
CHEMBL939
 2003
GEMCITABINE
CHEMBL888
 1996
DOCETAXEL
CHEMBL3545252
 1995
VINORELBINE
CHEMBL553025
 1994
PACLITAXEL
CHEMBL428647
 1992
NICLOSAMIDE
CHEMBL1448
 1982
MITOMYCIN
CHEMBL105
 1981
DOXORUBICIN
CHEMBL53463
 1974
VINBLASTINE
CHEMBL159
 1965
METHOTREXATE
CHEMBL34259
 1953
← Target Page
Source Header

ChEMBL 36 via Core Engine

Target Snapshot 2026-09-13T15:06:22Z
Source · ChEMBL 36 via Core Engine
ChEMBL ChEMBL 36 CHEMBL612264